Skip to main content

Cartesian Therapeutics, Inc.

RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001453687

No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Cartesian Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of RNAC: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders98101+3
Shares54.2M52.4M−1.81M (−3.3%)
Value$245.1M$219.2M−$26.0M (−10.6%)

New holders (18)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to RNAC in Q2 2021
InstitutionSharesValue% of portfolio
Marshall Wace, LLP304,297$1.27M0.01%
ClariVest Asset Management LLC168,900$706.0K0.02%
Banque Cantonale Vaudoise73,000$305.0K0.01%
Virtu Financial LLC57,919$242.0K0.02%
Susquehanna International Group, LLP40,281$168.0K0.00%
MetLife Investment Management36,162$151.2K0.00%
XTX Topco Ltd31,903$133.0K0.04%
Personal Cfo Solutions, LLC29,083$122.0K0.02%
Metropolitan Life Insurance Co26,638$111.3K0.00%
Pinz Capital Management, LP25,500$107.0K0.03%
Jane Street Group, LLC24,406$102.0K0.00%
Price T Rowe Associates Inc14,610$61.0K0.00%
Amalgamated Bank13,006$54.0K0.00%
Dynamic Technology Lab Private Ltd12,492$52.0K0.01%
Squarepoint Ops LLC11,717$49.0K0.00%
Los Angeles Capital Management LLC10,777$45.0K0.00%
STRS Ohio8,700$36.0K0.00%
Edmond de Rothschild Holding S.A.5,000$21.0K0.00%

Sold out (15)

Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.